resveratrol has been researched along with Edema-Proteinuria-Hypertension Gestosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Wang, Y; Yao, L | 1 |
| Jia, N; Shi, J; Sun, Q; Wang, J | 1 |
| Chen, D; Chen, Q; Cheng, W; Lang, X; Liu, W; Yang, X | 1 |
| Bertozzi-Matheus, M; Bueno-Pereira, TO; Caldeira-Dias, M; Cavalli, RC; Cinegaglia, N; Sandrim, VC; Viana-Mattioli, S | 1 |
| Caldeira-Dias, M; Carlström, M; de Carvalho Cavalli, R; de Souza Rangel Machado, J; Sandrim, VC; Viana-Mattioli, S | 1 |
| Beard, S; Brownfoot, FC; Cannon, P; Deo, M; Hannan, NJ; Kaitu'u-Lino, TJ; Nguyen, TV; Palmer, KR; Tong, S | 1 |
| Chan, ST; Cox, AG; Gurusinghe, S; Leaw, B; Lim, R; Marshall, SA; Mockler, JC; Muljadi, R; Murthi, P; Rahman, R; Singh, H; Wallace, EM | 1 |
| Jiang, Y; Jiang, Z; Li, S; Liu, F; Qu, H; Sun, L; Wang, S; Wang, X; Wang, Y; Wu, D; Xu, Y; Yu, X; Zou, Y | 1 |
| Barbieri, MA; Bettiol, H; Caldeira-Dias, M; Cardoso, VC; Cavalli, RC; Montenegro, MF; Sandrim, VC | 1 |
| Andersson, IJ; Baker, PN; Davidge, ST; Poudel, R; Rueda-Clausen, CF; Sibley, CP; Stanley, JL | 1 |
| Fan, M; Huang, S; Jiang, Z; Sun, L; Yu, X; Zou, S; Zou, Y; Zuo, Q | 1 |
| Engin-Ustun, Y; Ergün, H; Gacar, A; Guvenc, T; Moraloglu, O; Tapisiz, OL; Tonguç, E; Var, T | 1 |
| Ahmad, S; Ahmed, A; Al-Ani, B; Cai, M; Cudmore, MJ; Fujisawa, T; Ramma, W | 1 |
13 other study(ies) available for resveratrol and Edema-Proteinuria-Hypertension Gestosis
| Article | Year |
|---|---|
Resveratrol alleviates preeclampsia-like symptoms in rats through a mechanism involving the miR-363-3p/PEDF/VEGF axis.
Topics: Animals; Female; Humans; Hypertension; MicroRNAs; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Resveratrol; Trophoblasts; Vascular Endothelial Growth Factor A | 2023 |
A network pharmacology study on mechanism of resveratrol in treating preeclampsia
Topics: Child; ErbB Receptors; Female; Humans; Hypertension; Hypoxia-Inducible Factor 1; Infant; Interleukin-6; Molecular Docking Simulation; Network Pharmacology; Pre-Eclampsia; Pregnancy; Resveratrol | 2022 |
Resveratrol inhibits multiple organ injury in preeclampsia rat model.
Topics: Animals; Epinephrine; Female; Humans; Interleukin-6; Pre-Eclampsia; Pyruvates; Rats; Rats, Sprague-Dawley; Resveratrol; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia.
Topics: Adolescent; Adult; Antioxidants; Cell Survival; Female; Fruit and Vegetable Juices; Human Umbilical Vein Endothelial Cells; Humans; Pilot Projects; Pre-Eclampsia; Pregnancy; Resveratrol; Sirtuin 1; Treatment Outcome; Vitis; Young Adult | 2020 |
Resveratrol and grape juice: Effects on redox status and nitric oxide production of endothelial cells in in vitro preeclampsia model.
Topics: Adult; Antioxidants; Case-Control Studies; Female; Fruit and Vegetable Juices; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Oxidative Stress; Pilot Projects; Pre-Eclampsia; Pregnancy; Resveratrol; Vitis | 2021 |
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.
Topics: Antioxidants; Biomarkers; Blood Vessels; Cell Survival; Cytokines; Endoglin; Endothelium, Vascular; Female; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Nitric Oxide Synthase Type III; Oxidative Stress; Pre-Eclampsia; Pregnancy; Resveratrol; Trophoblasts; Vascular Endothelial Growth Factor Receptor-1 | 2017 |
Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2.
Topics: Activins; Antioxidants; Endothelial Cells; Female; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; NF-E2-Related Factor 2; Oxidative Stress; Pre-Eclampsia; Pregnancy; Resveratrol; Stilbenes; Trophoblasts; Vascular Endothelial Growth Factor Receptor-1 | 2017 |
Resveratrol promotes trophoblast invasion in pre-eclampsia by inducing epithelial-mesenchymal transition.
Topics: Animals; Antihypertensive Agents; beta Catenin; Cadherins; Cell Movement; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation; Humans; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Pre-Eclampsia; Pregnancy; Rats; Rats, Wistar; Resveratrol; Trophoblasts; Vimentin; Wnt Proteins; Wnt Signaling Pathway | 2019 |
Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia.
Topics: Adult; Antioxidants; Drug Evaluation, Preclinical; Endothelial Cells; Female; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Pre-Eclampsia; Pregnancy; Resveratrol; Young Adult | 2019 |
Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus.
Topics: Analysis of Variance; Animals; Blood Flow Velocity; Blood Pressure; Catechol O-Methyltransferase; Female; Fetal Growth Retardation; Fetal Weight; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Acoustic; Nitric Oxide Synthase Type III; Pre-Eclampsia; Pregnancy; Proteinuria; Regional Blood Flow; Resveratrol; Stilbenes; Uterus | 2013 |
Resveratrol inhibits trophoblast apoptosis through oxidative stress in preeclampsia-model rats.
Topics: Animals; Antioxidants; Apoptosis; Blood Pressure; Cell Line; Disease Models, Animal; Female; Hypoxia; Oxidative Stress; Phenotype; Placenta; Pre-Eclampsia; Pregnancy; Rats; Resveratrol; Stilbenes; Trophoblasts | 2014 |
The effect of resveratrol on blood pressure in a rat model of preeclampsia.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Female; Male; Pre-Eclampsia; Pregnancy; Rats; Rats, Wistar; Renal Circulation; Resveratrol; Stilbenes | 2012 |
Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta.
Topics: Cells, Cultured; Cytokines; Early Growth Response Protein 1; Enzyme Inhibitors; Female; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Placenta; Pre-Eclampsia; Pregnancy; Resveratrol; Stilbenes; Up-Regulation; Vascular Endothelial Growth Factor Receptor-1 | 2012 |